Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-09-12

Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Fixed-Dose Combination of Pitavastatin/Ezetimib

View source ↗

Summary

Recruiting update for a fixed-dose combination of pitavastatin and ezetimibe to evaluate efficacy and safety in primary hypercholesterolemia and mixed dyslipide…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pitavastatin/Ezetimibe fixed-dose combination (Pitavastatin; Ezetimibe)

Snippet

Sponsor: Boryung Pharmaceutical Co., Ltd | Conditions: Primary Hypercholesterolemia, Mixed Dyslipidemia | Status: RECRUITING